Figure 2From: Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: an economic analysis One-way sensitivity analyses show the lower and upper values for the cost-effectiveness ratio of the Gefitinib strategy to the Control strategy for each parameter. Back to article page